Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2683_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
40 Мб
Скачать
Confusion and delirium
— Hypertension
— Chronic liver
— Infection
Pattern of confusion
Delirium develops over 1–2 days. It is characterized by clouding of consciousness that fluctuates in severity, of­ten worse at night with lucid periods in the day. It can be accompanied by poor recent memory, disorientation and hallucinations. Delirium can be hypoactive (patients are withdrawn, quiet, sleepy), hyperactive (patients are restless, agitated and aggressive) or mixed (features of both).
Dementia has a gradual onset over months or years. It is a progressive global deterioration in higher cerebral func­tion, without effect on the level of consciousness. The symp-
familiar surroundings.
HINTS AND TIPS
Severe symptoms of delirium tremens due to alcohol withdrawal may occur more than 72 hours after the patient's last drink, and long after the patient has been admitted to hospital.
Underlying causes
The following should be assessed:
• Age: dementia becomes increasingly common after the
age of 60years.
• Symptoms of infection (see Chapter 8).
• Symptoms of raised intracranial pressure (see
Chapter16).
• Risk factors for, or known, vascular disease (see
Chapter27).
• Alcohol intake: long-term alcohol abuse can cause
dementia; it is also associated with thiamine deficiency (Wernicke–Korsakoff syndrome) and folate and B12 deficiency, both of which may increase the risk of dementia.
• Previous head injury or evidence of falls: subdural
haematoma.
• Other neurological symptoms: cerebrovascular
disease, multiple sclerosis, cerebral tumour/abscess, inflammatory or autoimmune neurological disease.
• Symptoms of endocrine disease: hypothyroidism or
hyperthyroidism, Addison disease.
• Medical history of any disease may be relevant:
long-standing renal disease (uraemia), liver disease (encephalopathy), malignancy (cerebral metastases, hypercalcaemia or paraneoplastic syndromes), diabetes (hypoglycaemia)
• Drug history: use of any sedatives, anticonvulsants and/or
steroids. Might the patient have consumed illicit drugs?
• Social history: confused patients often need a referral
to the safeguarding team, and understanding their social circumstances may help contextualize the presentation.
• Family history: Wilson disease (autosomal recessive); Huntington chorea (autosomal dominant).
• Brief psychiatric history: notably for features of depression or psychosis.
• Sexual history may provide information regarding the possibility of HIV infection, hepatitis or syphilis.
CLINICAL NOTES
CONFUSION ASSESSMENT METHOD
The Confusion Assessment Method (CAM) is a delirium-screening tool that helps identify patients with the condition. It comprises four questions:
1. Acute onset and fluctuating course?
2. Inattention?
3. Disorganized thinking?
4. Altered level of consciousness? Delirium is suggested if 1 and 2 and either 3 or 4 is present. The patient is then said to be ‘CAM positive’.
Examination
The approach to examining a patient presenting with confu­sion is summarized in Fig.19.1. Attention should be given to:
— Injury — Cyanosis — Otoscopy — Meningism
— Endocarditis — Heart failure
— Consolidation
disease
— Chronic liver disease — Clubbing liver flap
Fig.19.1 Examining the confused patient.
— Focal signs — Incontinence
— Hypotension
Skin
— Infection — Malignancy
— Glasgow coma scale — Capillary glucose — Mental state examination — Malignancy — Temperature — Oxygen saturation
118
History and examination findings
1919
• Consciousness: the level of consciousness should be recorded. Use the Glasgow Coma Scale score (see
Table18.3).
• Blood pressure: hypotension may be due to sepsis or cardiac failure. Hypertension is a risk factor for cerebrovascular events, and can also be a response to raised intracranial pressure.
• Signs of infection: measure temperature, look for neck stiffness, consolidation in the chest, signs of endocarditis, abdominal tenderness, otitis media on otoscopy and check pressure areas and skin for evidence of cellulitis (see Chapter8).
• Mental state: The 10-point abbreviated mental test score is useful to assess the level of confusion, and may be used serially to monitor progress.
• Focal neurological deficit and the pattern of signs may give important clues as to the diagnosis (see
Chapters20 and 22): fundoscopy should be performed,
looking for papilloedema (raised intracranial pressure), optic atrophy (demyelination) or subhyaloid haemorrhages (subarachnoid haemorrhage).
• Signs of chronic liver disease (CLD): hepatic encephalopathy can cause confusion. The presence of CLD may also indicate long-term alcohol abuse or rarer disorders, such as Wilson disease.
CLINICAL NOTES
ABBREVIATED MENTAL TEST SCORE
One point is awarded for each correct answer. A score of less than 7/10 strongly suggests confusion.
• Age.
• Date of birth.
• Time (to nearest hour).
• Current year.
• Address for recall at end of test – to be repeated by the patient to ensure it has been heard correctly (e.g. 42 West Street).
• Name of the place where we are.
• Recognition of two people (e.g. nurse and doctor).
• Beginning of First World War or similar.
• Name of monarch.
• Count backwards from 20 to 1.
Investigations
The investigations used in the diagnosis of delirium and de­mentia are very similar, although the urgency with which they are required is different. The following tests should be considered.
Bedside investigations
Routine observations, including oxygen saturation, cap­illary glucose, urinalysis and ECG, can all be performed quickly, and may give an almost immediate clue as to the underlying cause.
Blood tests
• Full blood count: infection or inflammation; anaemia with raised mean corpuscular volume in vitamin B12 or folate deficiency.
• Erythrocyte sedimentation rate: raised in malignancy, infection, inflammation.
• Urea and electrolytes: hyponatraemia or hypernatraemia, renal failure, uraemia.
• Liver function rests: abnormal results in liver disease.
• Thyroid function tests: thyroid-stimulating hormone level usually raised in hypothyroidism and low in hyperthyroidism.
• Serum calcium: hypercalcaemia or hypocalcaemia.
• Glucose: hypoglycaemia or hyperglycaemia; diabetic ketoacidosis or hyperosmolar hyperglycaemic state.
• Arterial blood gas: hypoxia and/or CO2 retention.
• Blood cultures if indicated.
• Vitamin B12 and folate levels: deficiency.
• Syphilis serology: tertiary syphilis may cause dementia.
Further tests
Consider the following when clinically indicated:
• Chest X-ray: pneumonia, cardiac failure, malignancy.
• CT/MRI of the head: tumour, stroke, age related changes.
• Urine: toxicology screen, culture for urinary infection.
• Lumbar puncture and CSF examination: protein, glucose, microscopy, culture and oligoclonal bands.
• Ammonia – level often raised in liver disease and metabolic disorders (see Chapter33).
• Serum copper and caeruloplasmin (reduced) and 24-hour urinary copper excretion (increased): Wilson disease.
Borrelia serology for Lyme disease.
• Thick and thin blood films: malaria.
• HIV serology.
CLINICAL NOTES
CONFUSION SCREEN
Patients presenting with new-onset confusion should undergo a variety of tests that are collectively termed the ‘confusion screen’. These include:
• full blood count, urea and electrolytes, liver function tests, clotting, thyroid function tests, calcium, vitamin B12 and folate, glucose.
• CT of the head.
• urine dipstick.
119
Confusion and delirium
Chapter Summary
• Delirium is very common amongst hospital patients.
• Delirium is difficult to diagnose and can often go unnoticed for prolonged periods. It is also challenging to treat. Pharmacological interventions should be used only as a last resort.
• As opposed to delirium, dementia is a condition of gradual onset that progresses over time. It is most common in the elderly population.
• There can be many causes of dementia, but the most common one is Alzheimer disease.
120

Stroke and TIA

20

INTRODUCTION

Stroke is a clinical syndrome where acute focal or global signs of cerebral dysfunction develop rapidly and persist for more than 24 hours. Deficits lasting less than 24 hours are termed ‘transient ischaemic attacks’ (TIAs). Different types of stroke and their causes are described in Table20.1. Eighty-five per- cent of strokes are ischaemic, and 15% are haemorrhagic.
The annual incidence of stroke is about 115 in 100,000
but rises with age; the incidence of TIA is approximately
Table20.1 Types of stroke
Type Causes
Haemorrhagic Hypertension
Ischaemic (thrombotic, hypotensive, occlusive)
Ischaemic (embolic)
MI, Myocardial infarction; PAN, polyarteritis nodosa; SLE, systemic lupus erythematosus.
Aneurysm (particularly Charcot– Bouchard microaneurysms; also berry and mycotic aneurysms) Arteriovenous malformation Tumours Bleeding tendency (thrombocytopenia, coagulopathy, anticoagulants) Drugs (amphetamines, ecstasy, cocaine) Haemorrhagic transformation of infarction
Hypertension Intracranial arterial atheroma Vasculitis (e.g., temporal arteritis, SLE, PAN, neurosyphilis) Prolonged hypotension (e.g., cardiac arrest) Thrombophilia (hyperviscosity, antiphospholipid syndrome) Drugs (amphetamines, ecstasy, cocaine) Arterial dissection (cervical or vertebral)
Carotid or vertebral atheroma Cardiac:
• Atrial fibrillation with left atrial thrombosis
• Endocarditis
• Ventricular thrombus, e.g., due to MI or ventricular aneurysm
• Atrial myxoma
Paradoxical:
• Venous thrombus can reach the cerebral circulation via an atrial septal defect
Table20.2 ABCD2 score for transient ischaemic attack
Feature Severity Score
Age >60years 1
Blood pressure
140/90 mmHg
Clinical features Unilateral weakness 2
Duration of
symptoms
Diabetes 1
Score 0–3, low risk; score 4–7, high risk.
1
Speech disturbance without weakness
Other 0
<10 min 0
10–59 min 1
60 min 2
1
190 in 100,000. The risk of developing a stroke following a TIA is around 17% at 3months. To aid the decision- making process regarding inpatient or outpatient management in patients after a TIA, risk stratification for experiencing a subsequent stroke is performed with a scoring system such as ABCD2 (Table20.2).
Stroke patients are at increased risk of experiencing another event. The 5-year recurrence rate is around 25%. shows the main risk factors for stroke; many are common to all vascular diseases (see Chapter27).
CLINICAL NOTES
RISK FACTORS FOR STROKE
• Previous stroke or transient ischaemic attack.
• Poorly controlled hypertension.
• Atrial fibrillation.
• Established vascular disease (carotid bruit, coronary artery disease, peripheral vascular disease).
• Diabetes mellitus.
• Hypercholesterolaemia.
• Thrombophilia.
• Family history.
• Smoking.
• Oral contraceptive pill use.
• Obesity.
• Excessive alcohol intake.
121
Stroke and TIA

CAUSES AND PATHOPHYSIOLOGY

The main causes of ischaemic stroke are thromboembolism from arteries and heart emboli (in atrial fibrillation, myocar­dial infarction or infective endocarditis). Uncommon causes of cerebral infarction include vasculitis, arterial dissection, ve­nous sinus thrombosis (which may also cause haemorrhage), polycythaemia and meningovascular syphilis (see below). Thrombus in situ may also occur in perforating arteries, of­ten due to lipohyalinosis as a complication of hypertension. Around 20% of ischaemic strokes occur in the posterior cere­bral circulation. The risk factors for TIA are identical, and the underlying disease processes are very similar, the main cause being embolism from a distant source. Other possible causes include thrombotic occlusion of small perforating vessels, low flow through stenosed vessels, vasculitis and haematological conditions such as sickle cell disease. Two or more TIAs occur­ring closely together (within 1week) may be due to an unstable plaque and are termed ‘crescendo TIA’. Crescendo TIA signifies a high risk of stroke.
Cerebral haemorrhage is usually due to rupture of per­forating arteries or intracerebral vessels (primary intracere­bral haemorrhage); underlying causes include hypertension (causing vessel fragility and microaneurysms), cerebral am­yloid angiopathy and arteriovenous malformations.
CLINICAL NOTES
DIFFERENTIAL DIAGNOSIS OF STROKE
• Transient ischaemic attack in the first 24 hours.
• Drug overdose.
• Hypoglycaemia.
• Subdural haemorrhage.
• Space occupying lesion.
• Epilepsy.
• Hemiplegic migraine.
HINTS AND TIPS
Amaurosis fugax is a so-called retinal TIA. It is an episode of transient monocular visual loss, and is most frequently a result of ischaemia.
• Where is the anatomical site of the lesion?
• Are any risk factors present?
Symptoms usually develop rapidly, but a stepwise pro­gressive neurological worsening over hours or days can also occur. Established deficit remains stable and usually abates over time. If there has been gradual neurological deterioration, consider one of the differential diagnoses or hydrocephalus secondary to the stroke (oedema or blood preventing free drainage of cerebrospinal fluid).
Any intracranial artery can be involved in stroke. The symptoms and signs will reflect which artery and therefore which part of the brain has been involved. This is summa­rized in Fig.20.1. The most common presentation is with hemiplegia due to occlusion of the middle cerebral or inter­nal carotid artery causing infarction of the internal capsule. Motor deficit is initially in the form of flaccid paralysis that later develops into spasticity. The presence of collateral ar­teries leads to variation in the presentation.
COMMUNICATION
Taking a history from a patient with a stroke can be challenging. The patient may have a receptive or expressive dysphasia, and could have visual impairment from a homonymous hemianopia. It is important to position yourself where the patient can see you to maximize communication with the patient. A collateral history may be required.
PATIENT SAFETY
FAST is a validated screening tool for the presence of neurological symptoms in patients presenting acutely. It stands for ‘face, arm, speech, time’, and is mostly used in an out-of-hospital setting for patients in whom a diagnosis of stroke is suspected.

HISTORY AND EXAMINATION FINDINGS

History
The history taking should focus on three distinct areas:
• Does the history fit with the diagnosis of stroke?
122
HINTS AND TIPS
If the patient has atrial fibrillation, calculate the patient’s risk of further stroke with a risk-scoring system such as the CHA2DS2-VASc score (Table20.3) to allow a reasoned decision regarding anticoagulation.
History and examination findings
— Sudden ataxia, sudden dysnomia
— Spinothalamic sensory loss
Circle of Willis
2020
Anterior cerebral artery
— Contralateral hemiparesis and hemisensory loss leg > arm — If dominant−−expressive dysphasia
Carotid artery
Posterior communicating
Carotid territory
artery
Posterior cerebral artery
— Contralateral homonymous hemianopia — Cortical blindness (Anton syndrome) — Contralateral hemisensory disturbance (thalamic syndrome)
Vertebrobasilar territory
— Involuntary movements
Vertebral artery
Lacunar infarcts
— Particularly in patients with hypertension — Small vessel occlusion — Internal capsule, basal ganglia, thalamus, brainstem can be affected — Pure motor or pure sensory disturbance
Anterior spinal artery
— Paraparesis
Anterior communicating artery
Middle cerebral artery
— Contralateral hemiparesis ± hemisensory loss arm and face > leg — If dominant−−expressive dysphasia — Contralateral homonymous hemianopia
Basilar artery
— Pontine stroke — Pinpoint pupils — Coma — Quadriplegia — Cardiorespiratory disturbance — Cranial nerve palsies
Posterior inferior cerebellar artery
— Lateral medullary syndrome (Wallenberg syndrome) — Ipsilateral 5th (sensory), 6th, 8th, 9th, 10th nerve palsy, nystagmus, ataxia, Horner syndrome — Contralateral spinothalamic sensory loss, hemiparesis (rare)
Fig.20.1 Symptoms and signs associated with different strokes. Note that haemorrhagic strokes have symptoms and signs determined by the site of the bleed. Patients may also develop headache, loss of consciousness and vomiting because of raised intracranial pressure.
Table20.3 CHA2DS2-VASc score for stroke risk with atrial fibrillation
Feature Score
Congestive heart failure 1
Hypertension history 1
Age 65–74years 1
Age 75years 2
Diabetes 1
Previous stroke/TIA/thromboembolism 2
Vascular disease history 1
• Is there any evidence of an underlying cause?
• Have any complications arisen because of the stroke?
• What immediate treatment is needed?
Fig.20.2 summarizes this examination approach.
A thorough neurological examination should be per­formed. The initial Glasgow Coma Scale (GCS) score should be recorded and then any changes should be doc­umented. The GCS is imperfect in stroke as dysphasia and aphasia reduce the verbal score. Does the pattern of neu­rological deficit fit with disruption of the cerebral vascular supply (see Fig.20.1)?
Female sex 1
A score of 2 or greater is generally taken as an indication for anticoagulation. TIA, transient ischaemic attack.
CLINICAL NOTES
STROKE CLASSIFICATION
Numerous different systems are used to classify
Examination
Clinical examination gives information regarding four im­portant areas in the stroke patient:
stroke. The Bamford classification is one of the more commonly used (Table20.4). One of its advantages is that it gives prognostic estimation.
• What are the neurological abnormalities, and do they fit with the diagnosis of stroke?
123
Stroke and TIA
Pulse
— Atrial fibrillation
r
Neurology
— Swallow assessment — Focal deficit
Neck
— Carotid artery bruits
Chest
— Signs of aspiration
Heart
— Murmur
General
— Glasgow coma scale — Capillary glucose
Head
— Injury — Xanthelasmata — Temporal artery tenderness
Blood pressure
— Hypotension — Hypertension
Hands
— Nicotine staining — Xanthomata
Legs
— Peripheral vascula disease — Femoral bruits
Fig.20.2 Examining the stroke patient.
Table20.4 The Bamford classification of stroke
Category
Total anterior circulation stroke Middle/anterior cerebral artery territory
Partial anterior circulation stroke
124
Percentage of overall strokes Clinical findings
20 All of (1) unilateral weakness of two
or more of face, arm and leg; with or without sensory deficit; (2) homonymous hemianopia; (3) disturbance of higher cerebral function, e.g., dysphasia, dyspraxia, inattention. If the patient is drowsy, then (2) and (3) are assumed
35 Any of the following: (1) two of the
components of total anterior circulation stroke; (2) higher cortical function deficit alone; (3) limited sensory or motor deficit
Percentage at 1year
Living
Deceased
independently
60 5
15 55
History and examination findings
Table20.4 The Bamford classification of stroke—Cont’d
Category
Lacunar stroke Infarcts involving: basal ganglia, internal capsule, thalamus and pons
Posterior circulation stroke 25 Brainstem and/or cerebellar deficits
Percentage of overall strokes Clinical findings
20 Pure motor or sensory stroke
or mixed affecting two-thirds of the face/arm/leg Sensorimotor stroke affecting two­thirds or more of the face/arm/leg Ataxic hemiparesis Dysarthria – clumsy hand syndrome No disturbance of higher function
(motor deficits of any combination of upper and lower limbs or the whole of the face; sensory deficits in any combination of upper and lower limbs or the whole of the face; or cerebellar signs – ataxia, imbalance, vertigo, diplopia, dysarthria, dysphagia) Isolated homonymous hemianopia
Percentage at 1year
Deceased
10 60
20 60
Living independently
2020
There are many causes of and risk factors for stroke. Particular attention should be paid to:
• Carotid bruits: carotid atheroma.
• Murmurs: endocarditis, valvular disease, atrial septal defect.
• Pulse: atrial fibrillation.
• Blood pressure: hypertension can be the cause or result of stroke; prolonged hypotension is also a risk factor.
• Diminished peripheral pulses and femoral bruits: peripheral vascular disease.
• Xanthelasmata, xanthomata: underlying hyperlipidaemia.
• Tar-stained fingers from smoking.
Complications are very common following stroke, both in the short term and during recovery, and are related to the extent of cerebral damage and the degree of neurological deficit. The more common problems, and prophylactic measures, are outlined in Table20.5.
Investigations
The diagnosis of stroke is clinical. The aim of immediate investigations is to look for treatable causes and to offer the best supportive care. The following investigations should be performed for any patient with an acute stroke:
Bedside investigations
• Capillary blood glucose: to rule out hypoglycaemia. Diabetes is associated with increased risk of stroke. Hypoglycaemia may present with stroke-like symptoms or signs, and prolonged severe hypoglycaemia may result in permanent brain injury.
Table20.5 Complications of stroke and measures to prevent them
Complications Prophylactic measures
Acute
Cerebral oedema (malignant middle cerebral artery syndrome)
Aspiration pneumonia Patients should be kept
Seizures None. Can be treated with
Subacute and long term
Pressure sores Careful nursing with regular
Contractures and spasticity Regular skilled
Malnutrition Feeding via a nasogastric
Depression Provision of adequate
Deep vein thrombosis Physiotherapy,
Particularly in haemorrhagic stroke and usually not preventable (avoid overenthusiastic rehydration). Surgical decompression is becoming more commonly performed
nil by mouth until they can swallow safely
antiepileptics. They may also occur later in the illness course as the brain remodels
turning on an air mattress
physiotherapy
tube or, later, gastrostomy
social and practical support
antiembolism stockings Heparin not used routinely
125
Stroke and TIA
• Routine bedside observations: blood pressure, pulse and oxygen saturations.
• ECG: this may show atrial fibrillation, or potentially (and much more rarely) ventricular aneurysm following recent myocardial infarction (persistent ST elevation, more than 2weeks after an ST-elevation myocardial infarction with pathological Q waves suggests a ventricular aneurysm).
Blood tests
• Full blood count: polycythaemia or thrombocytopenia may cause a stroke; a reactive picture may indicate inflammation (e.g., temporal arteritis).
• Erythrocyte sedimentation rate/C-reactive protein: level elevated in inflammation, vasculitis, infection and malignancy.
• Urea and electrolytes: renal impairment may either be due to or the cause of hypertension. It may also result from reduced oral intake or concurrent sepsis.
• Fasting lipids: hypercholesterolaemia is an important, treatable risk factor for stroke.
• Clotting: to assess the level of anticoagulation if the patient is receiving warfarin or to investigate suspected coagulopathy.
• Arterial blood gas: hypoxia should be treated. Seizure can lead to an increased lactate level.
Imaging
• Chest X-ray: an enlarged heart could indicate hypertension; an enlarged left atrium could suggest this being the point of origin for emboli.
• CT of the head: CT findings are often normal in the first few hours following an ischaemic stroke. The accuracy of the investigation increases after about 6 hours. Indications for immediate brain imaging are outlined in red flag: indications for urgent CT brain scan.
• MRI of the brain: this is preferred if a posterior circulation stroke is suspected as it provides better images of the posterior fossa. It is also helpful in cases of diagnostic uncertainty (especially to exclude tumour).
Further investigations
Depending on the patient and the clinical scenario, further tests may be required. The following further investigations should be considered, especially in young patients with no obvious risk factors:
• Blood cultures: infective endocarditis.
• Autoantibodies: to investigate the patient for vasculitis (antinuclear antibodies, antineutrophil cytoplasmic antibodies), antiphospholipid syndrome (anticardiolipin antibodies) or cerebral lupus (anti-double-stranded DNA).
• Carotid imaging: to look for carotid stenosis in patients with anterior circulation events (carotid territory); all patients considered as candidates for carotid endarterectomy (with or without stenting) should have this investigation.
• Cerebral angiography/venography or radiological equivalent: if there are additional signs or symptoms suggesting an unusual cause of infarction or haemorrhage, such as venous sinus thrombosis, arterial dissection or subarachnoid haemorrhage.
• Echocardiography: if cardiac embolus is suspected (e.g., after myocardial infarction, in endocarditis, in atrial fibrillation).
• Twenty-four-hour ECG monitoring: paroxysmal atrial fibrillation.
• Syphilis serology: neurosyphilis.
RED FLAG
INDICATIONS FOR URGENT CT BRAIN SCAN
• Thrombolysis or early anticoagulation treatment are considered.
• The patient is taking anticoagulants or has a known bleeding tendency.
• There is uncertainty as to the diagnosis (e.g., subdural or subarachnoid haemorrhage).
• There was severe headache at the onset of symptoms.
• There are progressive or fluctuating neurological signs.
• There is a reduced conscious level (Glasgow Coma Score <13).
• There is papilloedema, neck stiffness or fever.
RED FLAG
Patients with a suspected transient ischaemic attack should be assessed by a specialist urgently. Most patients require brain imaging. If the vascular territory or pathology is uncertain, imaging may be done at an urgent follow-up appointment. Imaging is helpful to exclude other causes of transient symptoms and to look for areas of previous silent infarction. Diffusion­weighted MRI is the investigation of choice. CT is used if MRI is contraindicated.
Management
Patients with established stroke should be admitted to hos­pital, ideally to a stroke unit.
Acute treatment
• An ABCDE approach should be instituted to ensure adequate oxygen saturations (95% unless contraindicated), haemodynamic stability (see clinical notes: blood pressure control in acute stroke), glucose
126
History and examination findings
2020
control (between 4 and 11 mmol/L), normothermia and electrolyte levels within the reference range.
• Thrombolysis with alteplase in selected patients with ischaemic stroke is beneficial when given up to 4.5 hours after symptom onset. Brain imaging is required before commencement of treatment to exclude haemorrhage.
• Antiplatelet agents: in acute ischaemic stroke, aspirin therapy (usually 300 mg daily) should be started immediately and no later than within 24 hours and should be continued for 2weeks, after which long-term secondary prevention is implemented (see later). Unless contraindicated, antiplatelet therapy should be started in all patients with TIA. In postthrombolysis patients, aspirin therapy is started 48 hours after the intervention.
Patients with a suspected TIA who are at high risk of stroke (ABCD2 score 4) should also be given aspirin (usu­ally 300 mg daily). Specialist assessment and investigations should occur within 24 hours of onset of symptoms but can be done in an outpatient setting.
• Anticoagulants: unless contraindicated, patients
with cerebral venous sinus thrombosis should be anticoagulated to an international normalized ratio target of 2–3.
• Swallow assessment: required to assess the risk of
aspiration. Give intravenous fluids if swallowing is compromised to maintain hydration. The speech and language therapy team and a dietitian should be involved early.
• Supportive therapy: monitoring for infection and
complications such as hydrocephalus; care of pressure areas, nutrition; physiotherapy; occupational therapy.
• Neurosurgical intervention may be indicated for
intracerebral haemorrhage or severe middle cerebral artery infarction. Malignant middle cerebral artery syndrome is a life-threatening cerebral oedema following ischaemic stroke.
encephalopathy, hypertensive nephropathy, hypertensive cardiac failure/myocardial infarction, aortic dissection, preeclampsia/ eclampsia, intracerebral haemorrhage with systolic blood pressure exceeding 200 mmHg.
• In patients considered for thrombolysis, the aim is to maintain the blood pressure below 185/100 mmHg.
Prevention
Secondary prevention following stroke and TIA should be initiated at diagnosis.
• Patient education and lifestyle changes: smoking cessation, physical activity, optimization of diet.
• Antiplatelet therapy: unless the patient has atrial fibrillation, clopidogrel (usually 75 mg daily) is used following ischaemic stroke or TIA. Dipyridamole is an alternative to aspirin and clopidogrel.
• Anticoagulant therapy: should be started in patients with atrial fibrillation or atrial flutter; this is started 14days after the event in the case of stroke and immediately in the case of TIA. Other indications for initiating anticoagulation include a cardiac source of embolism, cerebral venous thrombosis or arterial dissection. The risks and benefits of anticoagulation need to be considered and discussed with the patient. Anticoagulation is avoided in the first 2weeks following an acute cardioembolic stroke because of the risk of haemorrhagic transformation.
• Statins are recommended as primary prevention for patients with a 10-year risk of developing cardiovascular disease of 10% or more. In people with established cardiovascular disease, statin therapy should be started.
CLINICAL NOTES
BLOOD PRESSURE CONTROL IN ACUTE STROKE
• According to National Institute for Health and Care Excellence guidelines, antihypertensive medication is not recommended unless a hypertensive emergency occurs and at least one of the following is present: hypertensive
COMMUNICATION
If the patient is unconscious or consciousness is severely impaired, a decision as to the most appropriate degree of intervention should involve relatives/the next of kin. Factors to consider include prognosis, quality of life and if the patient had expressed any wishes in this regard.
127